
Zai Lab Limited ZLAB
$ 18.0
2.8%
Annual report 2025
added 02-26-2026
Zai Lab Limited Total Inventories 2011-2026 | ZLAB
Annual Total Inventories Zai Lab Limited
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 74.7 M | 39.9 M | 44.8 M | 31.6 M | 19 M | 13.1 M | 6 M | 3.82 K | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 74.7 M | 3.82 K | 28.6 M |
Quarterly Total Inventories Zai Lab Limited
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 67.1 M | 61.7 M | 53.1 M | 39.9 M | 39.5 M | 41.8 M | 37.9 M | 44.8 M | 44.2 M | 36.4 M | 38.4 M | 31.6 M | 29.1 M | 23.3 M | 20.3 M | 19 M | 12.5 M | 11.1 M | 12.6 M | 13.1 M | 13.1 M | 13.1 M | 13.1 M | 6 M | 889 K | - | - | 4 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 67.1 M | 4 K | 27.8 M |
Total Inventories of other stocks in the Biotechnology industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Verastem
VSTM
|
1.83 M | $ 5.04 | -4.73 % | $ 349 M | ||
|
Albireo Pharma
ALBO
|
194 K | - | -0.23 % | $ 916 M | ||
|
Arena Pharmaceuticals
ARNA
|
6.71 M | - | -6.81 % | $ 3.04 B | ||
|
Acorda Therapeutics
ACOR
|
16.2 M | - | -24.86 % | $ 820 K | ||
|
bluebird bio
BLUE
|
22.9 M | - | - | $ 546 M | ||
|
Avid Bioservices
CDMO
|
30.4 M | - | - | $ 789 M | ||
|
Adaptive Biotechnologies Corporation
ADPT
|
9.82 M | $ 12.41 | -11.1 % | $ 1.88 B | ||
|
Xeris Pharmaceuticals
XERS
|
68.7 M | $ 5.4 | -3.05 % | $ 866 M | ||
|
BeiGene, Ltd.
BGNE
|
608 M | - | 0.49 % | $ 251 B | ||
|
22nd Century Group
XXII
|
4.33 M | $ 2.41 | -18.03 % | $ 444 K | ||
|
BioDelivery Sciences International
BDSI
|
23.7 M | - | -4.8 % | $ 255 M | ||
|
Cara Therapeutics
CARA
|
2.82 M | - | -3.03 % | $ 260 M | ||
|
ChemoCentryx
CCXI
|
851 K | - | - | $ 3.74 B |